Reporting of Antibiotic-resistant Organisms in Nebraska

Nebraska Reportable Antibiotic-resistant Organisms

Effective January 28, 2001, select antibiotic-resistant organisms are reportable, see Nebraska Reporting and Control of Communicable Disease.  

Immediate reporting. Health care providers and laboratories need to immediately report cases of vancomycin-intermediate/resistant Staphylococcus aureus (VISA/VRSA)] [MIC > 4 m g/mL].

In addition to reporting of cases, laboratories are requested to forward VISA/VRSA isolates to the Nebraska Public Health Laboratory (NPHL) for confirmatory testing. For reporting forms, requisitions for NPHL, and contact information can be found at the Nebraska Department of Health and Human Services (Communicable Disease Program)

Monthly tabular reporting. Laboratories need to submit monthly reports of the number of isolates from all body sites for following if you do not submit lab reports via electronic laboratory reporting (ELR):

  • Streptococcus pneumoniae, penicillin-resistant (PRSP) [MIC>= 2.0 m g/mL], and penicillin-intermediate (PISP) [MIC = 0.12-1.0 m g/mL]
  • , penicillin-resistant (PRSP) [MIC>= 2.0 g/mL], and [MIC = 0.12-1.0 g/mL]
  • Enterococcus species, vancomyin-resistant (VRE) [MIC>=32 m g/mL and/or resistant by disk diffusion] and vancomycin-intermediate (VIE) [MIC = 8-16 m g/mL]
  • Staphylococcus aureus, methicillin-resistant (MRSA) [MIC>=4 m g/mL and/or resistant by disk diffusion]
  • Staphylococcus aureus, vancomycin-intermediate/resistant (VISA/VRSA) [MIC > 4 m g/mL]

In addition to the number of isolates of these reportable antibiotic-resistant organisms, the total number of Streptococcus pneumoniae, Enterococcus, and Staphylococcus aureus isolates identified and tested for susceptibility must be reported.


Antimicrobial Resistance Surveillance

Communicable Disease

Public Health